COMMUNIQUÉS West-GlobeNewswire

Saniona AB: Saniona publishes its interim report for the third quarter 2017

15/11/2017 - 08:02

PRESS RELEASE November 15, 2017 Financial highlights Jan - Sep 2017 (Jan - Sep 2016) · Net revenues were SEK 16.1 M (69.5 M) · EBIT was SEK -40.6 M (19.2 M) · Earnings per share were SEK -1.58 (0.70) · Diluted earnings [...]

Motif Bio secures up to US$20 million debt financing

15/11/2017 - 08:00

NEW YORK, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company has entered [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

15/11/2017 - 07:04

REGULATED INFORMATION GHENT, Belgium, 15 November 2017 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

INNATE PHARMA : Third quarter 2017 report

15/11/2017 - 07:01

Third quarter 2017 report Cash, cash equivalents and financial assets [*] amounting to €195.7 million Robust cash position allows for further investment in portfolio of proprietary immuno-oncology programs Innate Pharma [...]

INNATE PHARMA : Information financière du troisième trimestre 2017

15/11/2017 - 07:01

Information financiÈre du troisiÈme trimestre 2017 Trésorerie, équivalents de trésorerie et actifs financiers [*] s'élevant à 195,7 millions d'euros La solide position de trésorerie permet de continuer les [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

15/11/2017 - 07:01

REGULATED INFORMATION GHENT, Belgium, 15 November 2017 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

15/11/2017 - 02:00

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic [...]

Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options

15/11/2017 - 01:00

WINNIPEG, Manitoba, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q3 2017 Financial Results. Highlights: Total Revenues: For the nine [...]

TerrAscend Announces Appointment of Interim Chief Financial Officer

15/11/2017 - 00:52

TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) announces a change of Chief Financial Officer (“CFO”). Mr Roland Nimmo has replaced Ms. Rebecca Hudson in the [...]

Delcath Announces Third Quarter 2017 Financial Results

15/11/2017 - 00:41

NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]

Vigil Reports Record Sales Bookings in Second Quarter

14/11/2017 - 23:42

VICTORIA, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (TSX-VEN:VGL) (“Vigil”) announces the results of operations for the quarter ending September 30, 2017. Business Highlights Sales [...]

Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update

14/11/2017 - 23:40

Preliminary Data from PTI-428 + Orkambi 28 Day Clinical Study on Track for Q4 2017 Initial Data from PTI-801 + Orkambi 14 Day Clinical Trial Anticipated in Q4 2017 Initial Data from PTI-808 SAD and MAD HV 7 day Study [...]

Emergent BioSolutions Announces Notice of Termination of Conversion Rights of 2.875% Convertible Senior Notes Due 2021

14/11/2017 - 23:38

GAITHERSBURG, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) announced today that it has issued a Notice of Termination of Conversion Rights for all of its outstanding 2.875% Convertible [...]

Skyline Medical Reports 2017 Third Quarter Financial Results

14/11/2017 - 23:30

MINNEAPOLIS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

MEDITE Cancer Diagnostics Reports 2017 Third Quarter Financial Results

14/11/2017 - 23:25

ORLANDO, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical [...]

Sienna Senior Living Inc. Reports 2017 Third Quarter Financial Results

14/11/2017 - 22:54

MARKHAM, Ontario, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced its financial results for the three and nine months ended September 30, 2017. The [...]

Tivity Health Comments on North Tide Capital’s Plan for Divestiture of Tivity Stock

14/11/2017 - 22:50

North Tide Intends to Sell Remaining Holdings in Tivity Health via a 10b5-1 Trading Plan as Part of Wind Down of its Funds Conan Laughlin to Continue to Serve on Tivity Health Board of Directors FRANKLIN, Tenn., Nov. 14 [...]

Precision Optics Corporation, Inc. Announces Operating Results for the First Quarter of Fiscal Year 2018 Ended September 30, 2017

14/11/2017 - 22:30

GARDNER, Mass., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) today announced operating results on an unaudited basis for its first quarter ended September 30, 2017. [...]

Profound Medical Corp. to Present at the 29th Annual Piper Jaffray Healthcare Conference

14/11/2017 - 22:30

TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]